Stacey L. Ruiz, Ph.D.
Affiliations: | 2006 | The University of Texas Graduate School of Biomedical Sciences at Houston |
Area:
Oncology, Cell BiologyGoogle:
"Stacey Ruiz"Parents
Sign in to add mentor| David J. McConkey | grad student | 2006 | The University of Texas Graduate School of Biomedical Sciences at Houston | |
| (The effects of proteasome inhibition in chronic lymphocytic leukemia and prostate cancer.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Ruiz S, Krupnik Y, Keating M, et al. (2006) The proteasome inhibitor NPI-0052 is a more effective inducer of apoptosis than bortezomib in lymphocytes from patients with chronic lymphocytic leukemia. Molecular Cancer Therapeutics. 5: 1836-43 |
| Miller CP, Ban K, Ruiz SL, et al. (2005) The Novel, Orally Active Proteasome Inhibitor, NPI-0052, Induces Apoptosis in Leukemia Lymphoma Cell Lines and Patient Specimens. Blood. 106: 241-241 |
| Cortes J, Thomas D, Koller C, et al. (2004) Phase I study of bortezomib in refractory or relapsed acute leukemias. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 10: 3371-6 |